Shahla Shahsavandi
Overview
Explore the profile of Shahla Shahsavandi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mozafari A, Rahmani M, Yasini Nasab Y, Shahsavandi S, Jafari M, Salmanian A
Iran J Microbiol
. 2024 Nov;
16(5):655-665.
PMID: 39534294
Background And Objectives: The rapid spread of Newcastle disease (ND), driven by extensive commercial exchange in the poultry industry, necessitates urgent preventive measures. Although effective vaccines against the Newcastle disease...
2.
Shahsavandi S, Ebrahimi M, Nazari A, Khalili I
Vet Res Forum
. 2024 Mar;
15(1):49-55.
PMID: 38464605
Purification is an important step in the production of viral vaccines that strongly affects product recovery and subsequent immune responses. The present study was carried out with the aim of...
3.
Shahsavandi S, Torabi S, Ebrahimi M, Ghadiri M
Vet Immunol Immunopathol
. 2023 Sep;
264:110658.
PMID: 37748249
The infectious bursal disease virus (IBDV) causes an acute and highly contagious immunosuppressive response in young chickens by targeting B lymphocytes in immune organs. Changes in regulatory T-cell ratio and...
4.
Shahsavandi S, Hariri A
Viral Immunol
. 2023 Feb;
36(3):186-202.
PMID: 36796002
Emerging severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants have raised concerns about the efficacy of vaccines. The present study aimed to compare the potential of Delta and Omicron variant-specific mRNA...
5.
Mozafari A, Amani J, Shahsavandi S, Salmanian A
Iran J Biotechnol
. 2022 Nov;
20(2):e3119.
PMID: 36337069
Background: Newcastle disease, is one of the most important illnesses in the aviculture industry which shows a constant threat. In this case, the vaccine could be considered an important solution...
6.
Shahsavandi S, Ebrahimi M, Fotouhi F, Tebianian M
Viral Immunol
. 2022 May;
35(5):365-374.
PMID: 35527642
The effectiveness of inactivated H9N2 influenza vaccines is doubtful due to changes in antigenic regions of the virus hemagglutinin (HA) protein. One strategy for the development of the efficacious vaccine...
7.
Bagheri Yazdi S, Shahsavandi S, Fotouhi F, Tebianian M, Ebrahimi M
Iran J Allergy Asthma Immunol
. 2022 May;
21(2):207-214.
PMID: 35490274
Utilizing subunit vaccines is one of the strategies to address influenza infection. Recent innovations have focused on high doses of vaccine antigens and immune enhancers or adjuvant to induce more...
8.
Bagheri M, Khani M, Zahmatkesh A, Barkhordari M, Ebrahimi M, Asli E, et al.
Comp Immunol Microbiol Infect Dis
. 2022 Apr;
85:101796.
PMID: 35395519
The aim of the present study was to evaluate the potential effect of flagellin as adjuvant in Newcastle disease virus (NDV) vaccine on the cellular and humoral immunity in chickens....
9.
Shahsavandi S, Ebrahimi M, Ghadiri M, Samiee M
J Virol Methods
. 2022 Feb;
304:114502.
PMID: 35219784
Non-ionic surfactants have the ability to alter the cell membrane's permeability for enhancing virus replication. The impact of non-ionic surfactant Tween 80 (TW80) on the infectivity of infectious bursal disease...
10.
Barkhordari M, Bagheri M, Irian S, Khani M, Ebrahimi M, Zahmatkesh A, et al.
Comp Immunol Microbiol Infect Dis
. 2021 Feb;
75:101622.
PMID: 33607396
The present study was designed to investigate the potential application of native (N) and recombinant (truncated modified [tmFliC] and full-length [flFliC]) flagellin proteins along with inactivated Newcastle disease virus (NDV)....